Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds RSS Feed PharmiWeb Candidate Blog RSS Feed PharmiWeb Client Blog


Press Release

Global Otitis Media Pipeline Review 2016 - Research and Markets

Research and Markets
Posted on: 25 Aug 16

Research and Markets has announced the addition of the "Otitis Media - Pipeline Review, H2 2016" drug pipelines to their offering.

This report provides comprehensive information on the therapeutic development for Otitis Media, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Otitis Media and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Key Topics Covered:

  1. Introduction
  2. Otitis Media Overview
  3. Therapeutics Development
  4. Pipeline Products for Otitis Media - Overview
  5. Pipeline Products for Otitis Media - Comparative Analysis
  6. Otitis Media - Therapeutics under Development by Companies
  7. Otitis Media - Therapeutics under Investigation by Universities/Institutes
  8. Otitis Media Products Glance
  9. Late Stage Products
  10. Clinical Stage Products
  11. Early Stage Products
  12. Otitis Media - Products under Development by Companies
  13. Otitis Media - Products under Investigation by Universities/Institutes
  14. Otitis Media - Companies Involved in Therapeutics Development
  • Cellceutix Corporation
  • ContraFect Corporation
  • GlaxoSmithKline Plc
  • Lee's Pharmaceutical Holdings Limited
  • Madam Therapeutics B.V.
  • Merck & Co., Inc.
  • MerLion Pharmaceuticals Pte Ltd
  • Oticpharma Ltd
  • Otonomy, Inc.
  • Yuhan Corporation

For more information about this drug pipelines visit

Related Topics: Immune Disorders Drugs

View source version on

Business Wire

Last updated on: 25/08/2016

Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.